This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niitsu, Y. Articles by Kuriyama, H. Search for Related Content PubMed PubMed Citation Articles by Niitsu, Y. Articles by Kuriyama, H.

Induction of Synthesis of Tumor Necrosis Factor in Human and Murine Cell Lines by Exogenous Recombinant Human Tumor Necrosis Factor

Department of Internal Medicine (Section 4), Sapporo Medical College, South-1, West-16, Chuo-ku, Sapporo, 060, Japan

Treatment of sensitive human myosarcoma cells (KYM-S) with exogenous tumor necrosis factor (r-TNF) resulted in the production of TNF by the cells. The newly synthesized cellular TNF was identified immunologically on Western blots and as a single 1.8-kilobase band on Northern blots. TNF synthesis began within 2 h of administration of the exogenous TNF in a dose-dependent manner. r-TNF also induced TNF synthesis in mouse tumorigenic fibroblasts (L-M).

Resistant sublines of these cells as well as TNF nonsensitive human diploid fibroblasts possessed TNF mRNA without pretreatment, indicating an inverse correlation between levels of TNF expressed and sensitivity to the cytotoxic effects of exogenous TNF. It is conceivable that the newly synthesized cellular TNF functions in some protective manner to block cytolytic effects of exogenous TNF.

Received 11/20/87. Revised 4/11/88. Revised 6/ 6/88. Accepted 6/14/88.

This article has been cited by other articles:

				D. Kobayashi, N. Watanabe, N. Yamauchi, N. Tsuji, T. Sato, and Y. Niitsu Endogenous Tumor Necrosis Factor as a Predictor of Doxorubicin Sensitivity in Leukemic Patients Blood, April 1, 1997; 89(7): 2472 - 2479. [Abstract] [Full Text] [PDF]